Clinical and molecular characteristics of congenital glioblastoma

Neuro-Oncology

Volumn 14, Issue 7, 2012, Pages 931-941

  MacY, Margaret E ^a,d   Birks, Diane K ^c   Barton, Valerie N ^a,d   Chan, Michael H ^a,d   Donson, Andrew M ^a,d   Kleinschmidt Demasters, B K ^b,c,d   Bemis, Lynne T ^c   Handler, Michael H ^c,d   Foreman, Nicholas K ^a,d  

^a University of Colorado Denver and Children s Hospital Colorado   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CHILDREN S HOSPITAL COLORADO   (United States)

Author keywords

brain tumor; gene expression; glioblastoma; infant; microarray

Indexed keywords

CARBOPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; ETOPOSIDE; HISTONE H3; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR;

ARTICLE; BRAIN HEMORRHAGE; BRAIN SURGERY; BRAIN VENTRICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL ARTICLE; CONGENITAL GLIOBLASTOMA; CONGENITAL TUMOR; CONTROLLED STUDY; CYTOGENETICS; FALSE POSITIVE RESULT; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GLIOBLASTOMA; GLUCOSE METABOLISM; GROUPS BY AGE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOXEMIA; INFANT; MALE; MICROARRAY ANALYSIS; MULTIPLE CYCLE TREATMENT; NEWBORN; NUCLEOTIDE SEQUENCE; PROGRESSION FREE SURVIVAL; THALAMUS; TREATMENT OUTCOME; TREATMENT RESPONSE; TUMOR BIOPSY; TUMOR BLEEDING; TUMOR VOLUME; UNSPECIFIED SIDE EFFECT;

ADULT; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INFANT; INFANT, NEWBORN; MALE; NEOPLASM STAGING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 84862858688     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nos125     Document Type: Article

References (60)

1. Severino M, Schwartz ES, Thurnher MM, Rydland J, Nikas I, Rossi A. Congenital tumors of the central nervous system. Neuroradiology. 2010;52(6):531-548.
2. Mazewski CM, Hudgins RJ, Reisner A, Geyer JR. Neonatal brain tumors: a review. Semin Perinatol. 1999;23(4):286-298. (Pubitemid 29399384)
3. Rickert CH, Probst-Cousin S, Gullotta F. Primary intracranial neoplasms of infancy and early childhood. Childs Nerv Syst. 1997;13(10): 507-513. (Pubitemid 27517713)
4. Jellinger K, Sunder-Plassmann M. Connatal intracranial tumours. Neuropadiatrie. 1973;4(1):46-63.
5. Manoranjan B, Provias JP. Congenital brain tumors: diagnostic pitfalls and therapeutic interventions. J Child Neurol. 2011;26(5):599-614.
6. Hou LC, Bababeygy SR, Sarkissian V, et al. Congenital glioblastoma multiforme: case report and review of the literature. Pediatr Neurosurg. 2008;44(4):304-312. (Pubitemid 351931434)
7. Seker A, Ozek MM. Congenital glioblastoma multiforme. Case report and review of the literature. J Neurosurg. 2006;105(suppl 6):473-479. (Pubitemid 44968380)
8. Brat DJ, Shehata BM, Castellano-Sanchez AA, et al. Congenital glioblastoma: a clinicopathologic and genetic analysis. Brain Pathol. 2007; 17(3):276-281. (Pubitemid 47000636)
9. Rood BR, MacDonald TJ. Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches. J Neurooncol. 2005;75(3):267-272. (Pubitemid 43019481)
10. Winters JL, Wilson D, Davis DG. Congenital glioblastoma multiforme: a report of three cases and a review of the literature. J Neurol Sci. 2001;188(1-2):13-19. (Pubitemid 32727867)
11. Heckel S, Favre R, Gasser B, Christmann D. Prenatal diagnosis of a congenital astrocytoma: a case report and literature review. Ultrasound Obstet Gynecol. 1995;5(1):63-66.
12. Carstensen H, Juhler M, Bogeskov L, Laursen H. A report of nine newborns with congenital brain tumours. Childs Nerv Syst. 2006;22(11): 1427-1431. (Pubitemid 44650675)
13. Milano GM, Cerri C, Ferruzzi V, et al. Congenital glioblastoma. Pediatr Blood Cancer. 2009;53(1):124-126.
14. Finlay JL, Zacharoulis S. The treatment of high grade gliomas and diffuse intrinsic pontine tumors of childhood and adolescence: a historical-and futuristic-perspective. J Neurooncol. 2005;75(3): 253-266. (Pubitemid 43023756)
15. Halperin EC. Neonatal neoplasms. Int J Radiat Oncol Biol Phys. 2000;47(1):171-178. (Pubitemid 30179691)
16. Kalifa C, Grill J. The therapy of infantile malignant brain tumors: current status? J Neurooncol. 2005;75(3):279-285. (Pubitemid 43019483)
17. Geyer JR, Sposto R, Jennings M, et al. Multiagent chemotherapy and deferred radiotherapy in infants with malignant brain tumors: a report from the Children's Cancer Group. J Clin Oncol. 2005;23(30): 7621-7631. (Pubitemid 46291826)
18. Brennan C, Momota H, Hambardzumyan D, et al. Glioblastoma subclasses can be defined by activity among signal transduction pathways and associated genomic alterations. PLoS One. 2009;4(11):e7752.
19. Frederick L, Wang XY, Eley G, James CD. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 2000;60(5):1383-1387. (Pubitemid 30152011)
20. Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Oncogene. 1994;9(3):949-954. (Pubitemid 24065936)
21. Libermann TA, Nusbaum HR, Razon N, et al. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature. 1985; 313(5998):144-147. (Pubitemid 15192341)
22. Liu W, James CD, Frederick L, Alderete BE, Jenkins RB. PTEN/MMAC1 mutations and EGFR amplification in glioblastomas. Cancer Res. 1997;57(23):5254-5257. (Pubitemid 27516358)
23. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321(5897): 1807-1812.
24. Rasheed BK, McLendon RE, Herndon JE, et al. Alterations of the TP53 gene in human gliomas. Cancer Res. 1994;54(5):1324-1330. (Pubitemid 24108076)
25. Westermark B, Heldin CH, Nister M. Platelet-derived growth factor in human glioma. Glia. 1995;15(3):257-263.
26. Nobusawa S, Watanabe T, Kleihues P, Ohgaki H. IDH1 mutations as molecular signature and predictive factor of secondary glioblastomas. Clin Cancer Res. 2009;15(19):6002-6007.
27. Pollack IF, Finkelstein SD, Burnham J, et al. Age and TP53 mutation frequency in childhood malignant gliomas: results in a multi-institutional cohort. Cancer Res. 2001;61(20):7404-7407. (Pubitemid 32995024)
28. Pollack IF, Hamilton RL, Finkelstein SD, et al. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res. 1997;57(2):304-309. (Pubitemid 27036787)
29. Pollack IF, Hamilton RL, James CD, et al. Rarity of PTEN deletions and EGFR amplification in malignant gliomas of childhood: results from the Children's Cancer Group 945 cohort. J Neurosurg. 2006;105(suppl 5):418-424. (Pubitemid 44954773)
30. Pollack IF, Finkelstein SD, Woods J, et al. Expression of p53 and prognosis in children with malignant gliomas. N Engl J Med. 2002;346(6):420-427. (Pubitemid 34437697)
31. Kleinschmidt-DeMasters BK, Meltesen L, McGavran L, Lillehei KO. Characterization of glioblastomas in young adults. Brain Pathol. 2006;16(4):273-286.
32. Wu Z, Irizarry R, Gentleman R, Martinez M, Spencer F. A model-based background adjustment for oligonucleotide expression arrays. J Am Stat Assoc. 2004;99:909-917. (Pubitemid 39665934)
33. Smyth G. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004;3:Article 3.
34. Dennis G, Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 2003;4(5):P3.
35. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44-57.
36. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet. 2000;25(1):25-29. (Pubitemid 30257031)
37. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43): 15545-15550. (Pubitemid 41528093)
38. Phillips HS, Kharbanda S, Chen R, et al. Molecular subclasses of highgrade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell. 2006;9(3): 157-173. (Pubitemid 43357943)
39. Paugh BS, Qu C, Jones C, et al. Integrated Molecular Genetic Profiling of Pediatric High-Grade Gliomas Reveals Key Differences With the Adult Disease. Journal of Clinical Oncology. 2010;28(18):3061-3068.
40. Faury D, Nantel A, Dunn SE, et al. Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors. J Clin Oncol. 2007;25(10):1196-1208. (Pubitemid 46640565)
41. Kleinschmidt-DeMasters BK. Gamna-Gandy bodies in surgical neuropathology specimens: observations and a historical note. J Neuropathol Exp Neurol. 2004;63(2):106-112. (Pubitemid 38174775)
42. Hocwald O, McFadden D, Osiovich H, Dunham C. Congenital gliosarcoma: detailed clinicopathologic documentation of a rare neoplasm. Pediatr Dev Pathol. 2009;12(5):398-403.
43. Karremann M, Rausche U, Fleischhack G, et al. Clinical and epidemiological characteristics of pediatric gliosarcomas. J Neurooncol. 2010;97(2):257-265.
44. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97-109. (Pubitemid 47103521)
45. Mazzone D, Magro G, Lucenti A, Grasso S. Report of a case of congenital glioblastoma multiforme: an immunohistochemical study. Childs Nerv Syst. 1995;11(5):311-313.
46. Schwartzentruber J, Korshunov A, Liu XY, et al. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature. 2012;482(7384):226-231.
47. Wu G, Broniscer A, McEachron TA, et al. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat Genet. 2012;44(3):251-253.
48. Barrow J, Adamowicz-Brice M, Cartmill M, et al. Homozygous loss of ADAM3A revealed by genome-wide analysis of pediatric high-grade glioma and diffuse intrinsic pontine gliomas. Neuro Oncol. 2011;13(2):212-222.
49. Qu HQ, Jacob K, Fatet S, et al. Genome-wide profiling using singlenucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas. Neuro Oncol. 2010;12(2): 153-163.
50. Finlay JL, Boyett JM, Yates AJ, et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol. 1995;13(1):112-123.
51. Hales RK, Shokek O, Burger PC, et al. Prognostic factors in pediatric high-grade astrocytoma: the importance of accurate pathologic diagnosis. J Neurooncol. 2010;99(1):65-71.
52. Wisoff JH, Boyett JM, Berger MS, et al. Current neurosurgical management and the impact of the extent of resection in the treatment of malignant gliomas of childhood: a report of the Children's Cancer Group trial no. CCG-945. J Neurosurg. 1998;89(1):52-59. (Pubitemid 28285922)
53. Laws ER, Parney IF, Huang W, et al. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. J Neurosurg. 2003;99(3):467-473. (Pubitemid 37040405)
54. Sanai N, Polley MY, Berger MS. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression. J Neurosurg. 2010;112(1):1-9.
55. Sell M, Huber-Schumacher S, van Landeghem FK. Congenital glioblastoma multiforme with abnormal vascularity presenting as intracranial hemorrhage in prenatal ultrasound. Childs Nerv Syst. 2006;22(7): 729-733. (Pubitemid 43933698)
56. Shimamura N, Asano K, Ogane K, Yagihashi A, Ohkuma H, Suzuki S. A case of definitely congenital glioblastoma manifested by intratumoral hemorrhage. Childs Nerv Syst. 2003;19(10-11):778-781. (Pubitemid 37493221)
57. Thankamony A, Harlow FH, Ponnampalam J, Clarke P. Congenital brain tumour mimicking fetal intracranial haemorrhage. J Obstet Gynaecol. 2007;27(3):314-317. (Pubitemid 46676402)
58. Perry A, Aldape KD, George DH, Burger PC. Small cell astrocytoma: an aggressive variant that is clinicopathologically and genetically distinct from anaplastic oligodendroglioma. Cancer. 2004;101(10):2318-2326. (Pubitemid 39458690)
59. Huse JT, Phillips HS, Brennan CW. Molecular subclassification of diffuse gliomas: seeing order in the chaos. Glia. 2011;59(8):1190-1199.
60. Hartmann C, Hentschel B, Wick W, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol. 2010;120(6):707-718.